PHAT Q2 2023 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$123,000

Operating Income

-$32M

Net Income

-$41M

EPS (Diluted)

$-0.84

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$265M

Total Liabilities

$247M

Stockholders' Equity

$18M

Cash & Equivalents

$249M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$123,000	-$149,000	+17.4%
Operating Income	-$32M	-$45M	+30.1%
Net Income	-$41M	-$51M	+19.6%